Loading presentation...

Present Remotely

Send the link below via email or IM

Copy

Present to your audience

Start remote presentation

  • Invited audience members will follow you as you navigate and present
  • People invited to a presentation do not need a Prezi account
  • This link expires 10 minutes after you close the presentation
  • A maximum of 30 users can follow your presentation
  • Learn more about this feature in our knowledge base article

Do you really want to delete this prezi?

Neither you, nor the coeditors you shared it with will be able to recover it again.

DeleteCancel

Make your likes visible on Facebook?

Connect your Facebook account to Prezi and let your likes appear on your timeline.
You can change this under Settings & Account at any time.

No, thanks

Unethical Practices Of Pharmaceutical Companies

No description
by

Michael McGarroch

on 25 October 2013

Comments (0)

Please log in to add your comment.

Report abuse

Transcript of Unethical Practices Of Pharmaceutical Companies

Unethical Practices Of Pharmaceutical Companies
Facts
$4.1 Trillion dollars is spent globally on heath services each year

$750 Billion is spent in the global pharmaceutical market

10-25% of public procurement spending is lost to corrupt practices

In developing countries up to 89% leakage of procurement and operational costs have been observed
Impact On Companies

Unethical practices lead to reduced availability of medicines in health facilities

Diverted, counterfeit and substandard medicines have been identified in both rich and poor countries

Leads to patient suffering and direct life or death consequences

Fraud and abuse in health care has been estimated to cost individual governments $12-23 billion dollars per year

Pharmaceutical corruption within ministries of health has also threatened the withdrawal of donor contributions in some low-income countries
Impact On Stakeholers

Discussion Questions
What Are Unethical Practices of Pharmaceutical Companies?
An unethical pharmacist is essentially one who fails to be responsible for dispensing/compounding drugs

Failing to prepare suitable dosage forms for their clients

Price manipulation

Unprofessional methods to boost sales

Pharmacist giving patients less than needed or to provide more than necessary
Watch This!
Employees
Ethical Dilemma
Bad examples set by their manager/boss
If caught the pharmacy is labeled negatively and becomes no longer profitable
Impact on Suppliers, Community, and Customers
When suppliers supply products to unethical pharmacies they expect to get paid back according to how much they supply
Bad for the community because they can lose their pharmacy provider due to loss of license and its privilege to bill of government
Due to the pharmacy not being able to fill prescriptions this can create an inconvenience to the customers health and well-being

Protests

In the United States and other rich industrialized nations, “big pharma” is already the gatekeeper for life-saving medicines. The Global South is the next frontier in the patent war, where public health advocates form the front line against an industry seeking to colonize nascent health care markets.

In April Cambodian activists issued a statement in opposition to the EU trade deal with India, warning that the price of medicine would skyrocket and cost lives.

It is a true example of putting profits before people’s lives and [taking] advantage of people’s illness for corporate profits. Our lives should not be regarded as a business opportunity.”

Their protest comes in the face of an even larger pending agreement: the Trans-Pacific Partnership Agreement (TTP), a free trade scheme central to the Obama administration’s “pivot to Asia.”
How can this be improved?
thorough checks and balances are required at each step in the medicines chain.

Good governance, transparency, accountability, promoting institutional integrity and moral leadership are also essential.

WHO is committed to reducing corruption in the medicines chain through its Good Governance for Medicines (GGM) programme

By applying transparent, accountable administrative procedures and by promoting ethical practices, GGM provides support for countries to curb corruption.
the Health Care Fraud Prevention and Enforcement Action Team (HEAT) initiative, which was announced in May 2009 by Attorney General Eric Holder and Kathleen Sebelius, Secretary of HHS. The partnership between the two departments has focused efforts to reduce and prevent Medicare and Medicaid financial fraud through enhanced cooperation.
Over the last three years, the department has recovered a total of more than $10.2 billion in settlements, judgments, fines, restitution, and forfeiture in health care fraud matters pursued under the False Claims Act and the Food, Drug and Cosmetic Act.
1. if you to pick one, would you blame pharmacies or doctors in terms of customers getting more ill from medication or even potentially dying?

2. Has anyone here ever been involved with a pharmaceutical dilemma with a doctor or pharmacist?
Full transcript